Press Releases

GOOSE CREEK, SC / ACCESSWIRE / May 15, 2024 / HireQuest, Inc. (Nasdaq: HQI), a national franchisor of direct dispatch, executive search, and commercial staffing services, today announced that its Board of Directors has declared a quarterly dividend of $0.06 per share. The dividend is payable June 17, 2024, to shareholders of record at the close of business on June 3, 2024.

About HireQuest

HireQuest, Inc. is a nationwide franchisor of direct dispatch, executive search, and... (continue reading...)

BAY SHORE, N.Y.--(BUSINESS WIRE)-- Air Industries Group (NYSE American: AIRI), a leading manufacturer of precision components and assemblies for large aerospace and defense prime contractors, today reported financial results for the first quarter and updated its 2024 business outlook.

“Fiscal 2024 is off to a good start. The strong order and opportunity flow we experienced during the fourth quarter of last year continues and remains strong. We achieved bookings... (continue reading...)

LITTLE ROCK, Ark., May 15, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, and Vice President, Investor Relations & Treasury, Bill DiTullio, are scheduled to participate at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference on May 22, 2024 in Boston, MA.

Any investor materials will be made available on Uniti’s Investor Relations... (continue reading...)

NORFOLK, Va., May 15, 2024 /PRNewswire/ -- PRA Group, Inc. (Nasdaq: PRAA) (the "Company"), a global leader in acquiring and collecting nonperforming loans, announced today the pricing on May 15, 2024 of its offering of $400.0 million aggregate principal amount of 8.875% Senior Notes due 2030 (the "notes"), in a private transaction that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The offering of the... (continue reading...)

SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the first quarter ended March 31, 2024, and provided an update on its corporate activities and product pipeline.

“Our... (continue reading...)